It was first shown that TLR2/TLR4- MyD88-mediated signaling was required for the optimal function of MDSCs and suppression of anti-tumor immunity in models of colon cancer and fibrosarcoma, suggesting an involvement of canonical NF-κB activation [44,45]. The gene discussed is NFKB1; the disease is neoplasm.